PS06-002 Rap Test Algorithm in Non-Trad Test Stes to Improve Linkage to Care

PS06-002 非传统测试步骤中的 Rap 测试算法,以改善与护理的联系

基本信息

  • 批准号:
    7222920
  • 负责人:
  • 金额:
    $ 24.26万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-09-30 至 2008-09-29
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The specific aims of this project are to: a) develop written protocols for utilizing a diagnostic rapid testing algorithm, b) identify best practices for implementation, c) evaluate the advantages and disadvantages of such an algorithm, d) to validate the use of a diagnostic rapid HIV testing algorithm, e) assess the proportion of non-HIV-infected clients who receive a preliminary positive result according to the algorithm as opposed to current practice, f) assess the proportion of HIV-infected clients who receive disclosure of a confirmed HIV positive test result according to the algorithm as opposed to current practice, g) assess the proportion of HIV-infected clients who are referred to and receive primary medical care as a result of diagnosis through the algorithm as opposed to current practice, h) assess the cost of HIV testing with a diagnostic algorithm. The broad, long-term objectives of this project are in line with the agencies' missions to: a) increase the number of HIV-infected individuals who learn their status and enter into early medical care and prevention services to prevent transmission to others, b) reduce the burden of rapid HIV testing program implementation and maintenance on the staff of performance sites, and c) improve the efficiency and quality of HIV testing services available for high-risk and hard to reach clientele. Seven intervention sites will be providing rapid HIV testing according to the following algorithm: an FDA approved CLIA-waived rapid test will be run. If the test is reactive, a second CLIA-waived rapid test will be run. If that test is also reactive, the client will be diagnosed as HIV-positive and linked to medical care. Blood will be drawn and an appointment will be scheduled for one week later to disclose the results of confirmatory testing. If the second rapid test is non-reactive, then a third rapid test will be run to determine diagnosis and blood will be drawn for confirmation. Thirteen comparison sites will be providing rapid HIV testing according to the current standard of practice: a CLIA-waived rapid HIV test is run, and if preliminary positive, blood is drawn for confirmation. At the confirmatory disclosure appointment one week later, the client is diagnosed with HIV and linked to medical care. Assistance will be provided to both intervention and comparison sites to enhance the tracking of linkages to medical care and other necessary support services for all individuals testing HIV-positive. This research is relevant to public health because early identification of HIV-positive people and linkage to medical care reduces the rate of transmission and the burden of providing late-diagnosis medical care.
描述(由申请人提供):该项目的具体目标是:a)制定使用诊断性快速检测算法的书面协议;b)确定实施的最佳做法;c)评估这种算法的优缺点;d)验证诊断性艾滋病毒快速检测算法的使用;e)评估根据该算法而不是目前的做法获得初步阳性结果的未感染艾滋病毒客户的比例。f)评估根据算法(而不是现行做法)得知确认的艾滋病毒阳性检测结果的艾滋病毒感染客户的比例;g)评估通过算法(而不是现行做法)诊断后转诊并接受初级医疗保健的艾滋病毒感染客户的比例;h)评估使用诊断算法进行艾滋病毒检测的费用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TERI DOWLING其他文献

TERI DOWLING的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TERI DOWLING', 18)}}的其他基金

PS06-002 Rap Test Algorithm in Non-Trad Test Stes to Improve Linkage to Care
PS06-002 非传统测试步骤中的 Rap 测试算法,以改善与护理的联系
  • 批准号:
    7686652
  • 财政年份:
    2006
  • 资助金额:
    $ 24.26万
  • 项目类别:
PS06-002 Rap Test Algorithm in Non-Trad Test Stes to Improve Linkage to Care
PS06-002 非传统测试步骤中的 Rap 测试算法,以改善与护理的联系
  • 批准号:
    7284259
  • 财政年份:
    2006
  • 资助金额:
    $ 24.26万
  • 项目类别:

相似海外基金

The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
  • 批准号:
    10715568
  • 财政年份:
    2023
  • 资助金额:
    $ 24.26万
  • 项目类别:
CAPRISA CASCADE Clinical Trials Network Clinical Research Site
CAPRISA CASCADE 临床试验网络临床研究网站
  • 批准号:
    10754981
  • 财政年份:
    2023
  • 资助金额:
    $ 24.26万
  • 项目类别:
TO PROVIDE BIO-MEDICAL AND BEHAVIORAL RESEARCH RESOURCES AND CLINICAL RESEARCH COORDINATING SERVICES TO SUPPORT THE NIDA CLINICAL TRIALS NETWORK (CTN)
提供生物医学和行为研究资源以及临床研究协调服务以支持 NIDA 临床试验网络 (CTN)
  • 批准号:
    10617997
  • 财政年份:
    2022
  • 资助金额:
    $ 24.26万
  • 项目类别:
TO PROVIDE BIO-MEDICAL AND BEHAVIORAL RESEARCH RESOURCES AND CLINICAL RESEARCH COORDINATING SERVICES TO SUPPORT THE NIDA CLINICAL TRIALS NETWORK (CTN)
提供生物医学和行为研究资源以及临床研究协调服务以支持 NIDA 临床试验网络 (CTN)
  • 批准号:
    10538151
  • 财政年份:
    2021
  • 资助金额:
    $ 24.26万
  • 项目类别:
Health 360x Clinical Research Platform for Scalable Access to Clinical Trials
Health 360x 临床研究平台可扩展临床试验的访问
  • 批准号:
    10624966
  • 财政年份:
    2021
  • 资助金额:
    $ 24.26万
  • 项目类别:
Health 360x Clinical Research Platform for Scalable Access to Clinical Trials
Health 360x 临床研究平台可扩展临床试验的访问
  • 批准号:
    10515803
  • 财政年份:
    2021
  • 资助金额:
    $ 24.26万
  • 项目类别:
Health 360x Clinical Research Platform for Scalable Access to Clinical Trials
Health 360x 临床研究平台可扩展临床试验的访问
  • 批准号:
    10258627
  • 财政年份:
    2021
  • 资助金额:
    $ 24.26万
  • 项目类别:
New Mexico Clinical Trials Node: Clinical research and practice to address substance use in diverse, rural and underserved populations
新墨西哥州临床试验节点:解决多样化、农村和服务不足人群的药物使用问题的临床研究和实践
  • 批准号:
    10581505
  • 财政年份:
    2019
  • 资助金额:
    $ 24.26万
  • 项目类别:
New Mexico Clinical Trials Node: Clinical research and practice to address substance use in diverse, rural and underserved populations
新墨西哥州临床试验节点:解决多样化、农村和服务不足人群的药物使用问题的临床研究和实践
  • 批准号:
    10379715
  • 财政年份:
    2019
  • 资助金额:
    $ 24.26万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了